Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients

Introduction: The prognosis of glioblastoma (GBM) treated with standard-of-care maximal surgical resection and concurrent adjuvant temozolomide (TMZ)/radiotherapy remains very poor (less than 15 months). GBMs have been found to contain a small population of cancer stem cells (CSCs) that contribute t...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Candace M., Valluri, Jagan, Alberico, Anthony, Julien, Terrence, Mazagri, Rida, Marsh, Robert, Alastair, Hoyt, Cortese, Antonio, Griswold, Michael, Wang, Wanmei, Denning, Krista, Brown, Linda, Claudio, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310181/
https://www.ncbi.nlm.nih.gov/pubmed/28199863
http://dx.doi.org/10.1016/j.tranon.2017.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310181/
https://www.ncbi.nlm.nih.gov/pubmed/28199863
http://dx.doi.org/10.1016/j.tranon.2017.01.008

Ejemplares similares